Literature DB >> 2572291

Presynaptic beta-adrenoceptors in rat atria: evidence for the presence of stereoselective beta 1-adrenoceptors.

M Heimburger1, M J Montero, V Fougeres, F Beslot, M Davy, M Midol-Monnet, Y Cohen.   

Abstract

1. Presynaptic beta-adrenoceptor activity was studied in rat isolated atria, previously loaded with [3H]-noradrenaline. The stimulation-induced release of 3H transmitter was measured in the presence of cocaine, and adrenaline was used as a facilitatory beta-adrenoceptor agonist. 2. Adrenaline (0.1 and 2 nM) increased, by about 50%, the evoked efflux of tritium. With phenoxybenzamine present, the same activity was shown with 10 nM adrenaline. 3. The beta 2-selective adrenoceptor blocking drugs: IPS 339 and ICI 118 551 caused a concentration-dependent decrease in the activity of adrenaline. Cardioselective beta-blocking drugs: acebutolol, beta-xolol, nebivolol and its isomers (R 67 138 and R 67 145) also reduced dose-dependently the agonistic action of adrenaline. The order of potency for nebivolol and its isomers was R 67 138 greater than nebivolol greater than R 67 145. The activity of pindolol was not concentration-dependent. The inhibitory effect of acebutolol was also observed in the presence of blockade of alpha-adrenoceptors. 4. The postsynaptic beta-adrenoceptor blocking activity of nebivolol and its isomers was studied in pithed rats. They reduced isoprenaline-induced tachycardia without altering hypotensive responses. The order of potency was: R 67 138 greater than nebivolol greater than R 67 145. 5. It is concluded that in rat isolated atria, presynaptic beta 2- and beta 1-adrenoceptors coexist and that facilitatory beta 1-adrenoceptors are stereospecific.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2572291      PMCID: PMC1854684          DOI: 10.1111/j.1476-5381.1989.tb16884.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  Studies on beta-adrenoceptor mediated facilitation of sympathetic neurotransmission.

Authors:  C Dahlöf
Journal:  Acta Physiol Scand Suppl       Date:  1981

Review 2.  Pindolol--the pharmacology of a partial agonist.

Authors:  B J Clark; K Menninger; A Bertholet
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

3.  Activation of prejunctional beta-adrenoceptors in rat atria by adrenaline applied exogenously or released as a co-transmitter.

Authors:  H Majewski; M J Rand; L H Tung
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

4.  Adrenaline activation of prejunctional beta-adrenoceptors in guinea-pig atria.

Authors:  H Majewski; M W McCulloch; M J Rand; D F Story
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

5.  Adrenaline activation of prejunctional beta-adrenoceptors and hypertension.

Authors:  H Majewski; L H Tung; M J Rand
Journal:  J Cardiovasc Pharmacol       Date:  1982 Jan-Feb       Impact factor: 3.105

6.  Further characterization of presynaptic beta-adrenoceptors in guinea-pig pulmonary arteries.

Authors:  Y Misu; M Kuwahara; M Kaiho; T Kubo
Journal:  Eur J Pharmacol       Date:  1983-07-22       Impact factor: 4.432

7.  The effects of (+)- and (-)-propranolol on 3H-transmitter efflux in guinea-pig atria and the presynaptic beta-adrenoceptor hypothesis.

Authors:  S Kalsner
Journal:  Br J Pharmacol       Date:  1980-11       Impact factor: 8.739

Review 8.  Modulation of noradrenaline release through activation of presynaptic beta-adrenoreceptors.

Authors:  H Majewski
Journal:  J Auton Pharmacol       Date:  1983-03

Review 9.  Presynaptic beta-adrenoceptors.

Authors:  Y Misu; T Kubo
Journal:  Med Res Rev       Date:  1986 Apr-Jun       Impact factor: 12.944

10.  Presynaptic regulation of the release of catecholamines.

Authors:  S Z Langer
Journal:  Pharmacol Rev       Date:  1980-12       Impact factor: 25.468

View more
  1 in total

Review 1.  Newer beta blockers and the treatment of hypertension.

Authors:  D McAreavey; R Vermeulen; J I Robertson
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.